Intraoperative Pyloric Botulinum Toxin Injection for Post Total Pancreatectomy With Islet Autotransplantation Gastroparesis Improvement in Children
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Apr 2025 · 1 min read
In brief
In brief
This retrospective study demonstrates that intraoperative pyloric botulinum toxin injection during total pancreatectomy with islet autotransplantation significantly reduces post-operative gastroparesis in pediatric patients. Children receiving botulinum toxin achieved full oral nutrition 11 days earlier and required fewer gastrostomy tube drainage days compared to controls.
Written by the GCMD Library team from the article.
Statements in this article
Total pancreatectomy with islet autotransplantation is an option for acute recurrent pancreatitis and chronic pancreatitis when other measures fail.
Pancreatitis gastroparesis can be potentiated by surgery.
Botulinum toxin injections into the pylorus have been used in children for gastroparesis.
Children who received pyloric botulinum toxin during total pancreatectomy with islet autotransplantation had fewer days to achieve full oral nutrition compared to those who did not receive it (29.4 days versus 40.9 days, p < 0.01).
Children who received pyloric botulinum toxin had fewer gastrostomy tube drainage days through postoperative day 14 compared to those who did not (7.2 days versus 10.1 days, p < 0.01).
There was no significant difference in emesis days through postoperative day 14 between children who received pyloric botulinum toxin and those who did not (2.7 days versus 4.2 days, p = 0.21).
There was no significant difference in percent weight change at discharge between children who received pyloric botulinum toxin and those who did not (-2.9% versus -4.6%, p = 0.07).
There was no significant difference in length of stay between children who received pyloric botulinum toxin and those who did not (median 15.5 days versus 16 days, p = 0.46).